Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma.
Times cited: 3
Pilot trial of selecting molecularly guided therapy for patients with non-V600 BRAF-mutant metastatic melanoma: Experience of the SU2C/MRA melanoma dream team.
Molecular Cancer Therapeutics.
Times cited: 11